Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial.
Pinyo RattanaumpawanPeerawong WerarakAnupop JitmuangPattarachai KiratisinVisanu ThamlikitkulPublished in: BMC infectious diseases (2017)
ClinicalTrials.gov identifier: NCT01297842 . Registered on 14 February 2011. First patient enrolled on 27 June 2011.